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Introduction
Ibuprofen (IBU) is a non-steroidal anti-inflammatory drug 
that belongs to arylpropionic acid derivatives1 and is chemically 
(RS)-2-(4-(2-methylpropyl)phenyl)propanoic acid. Paracetamol 
or acetaminophen (PARA) is a widely used over-the-counter 
analgesic (pain reliever) and antipyretic (fever reducer), and it 
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ABSTRACT: A rapid and stability-indicating reversed phase high-performance liquid chromatography (RP-HPLC) method was developed for simultaneous 
quantification of paracetamol and ibuprofen in their combined dosage form especially to get some more advantages over other methods already developed 
for this combination. The method was validated according to United States Pharmacopeia (USP) guideline with respect to accuracy, precision, specificity, 
linearity, solution stability, robustness, sensitivity, and system suitability. Forced degradation study was validated according to International Conference on 
Harmonisation (ICH). For this, an isocratic condition of mobile phase comprising phosphate buffer (pH 6.8) and acetonitrile in a ratio of 65:35, v/v at a flow 
rate of 0.7 mL/minute over RP C18 (octadecylsilane (ODS), 150 × 4.6 mm, 5 μm, Phenomenex Inc.) column at ambient temperature was maintained. The 
method showed excellent linear response with correlation coefficient (R2) values of 0.999 and 1.0 for paracetamol and ibuprofen respectively, which were 
within the limit of correlation coefficient (R2  0.995). The percent recoveries for two drugs were found within the acceptance limit of (97.0–103.0%). Intra- 
and inter-day precision studies of the new method were less than the maximum allowable limit percentage of relative standard deviation (%RSD)  2.0. 
Forced degradation of the drug product was carried out as per the ICH guidelines with a view to establishing the stability-indicating property of this method 
and providing useful information about the degradation pathways, degradation products, and how the quality of a drug substance and drug product changes 
with time under the influence of various stressing conditions. The degradation of ibuprofen was within the limit (5–20%, according to the guideline of ICH), 
while paracetamol showed 20% degradation in oxidation and basic condition.
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belongs to para-aminophenol derivatives1 and is chemically 
N-(4-hydroxyphenyl) acetamide as shown in Figure 1.
Combination of ibuprofen and paracetamol (200/500 mg) 
tablets is frequently indicated for temporary relief of mild to 
moderate pain associated with migraine, headache, back-
ache, period pain, dental pain, rheumatic and muscular pain, Asma et al
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non-serious arthritis pain, cold and flu symptoms, sore throat, 
and fever.2 This product is especially suitable for pain that 
requires stronger analgesia than ibuprofen or paracetamol 
alone.3 Development of an analytical method for assessment 
of drugs in pharmaceutical dosage form is of utmost neces-
sity to confirm the quality of tablets or capsules with respect 
to assay, content uniformity, and dissolution. There are com-
pendial methods for assessment of these two drugs singly in 
United States Pharmacopeia (USP) and British Pharmacopeia 
(BP). A number of high-performance liquid chromatography 
(HPLC) methods have been already stated for determina-
tion of ibuprofen and paracetamol in their combination dos-
age form.4–8 But we found some drawbacks in those methods, 
which are listed below:
•	 Almost all of those methods have used organic solvents 
more than 50%, which is not cost effective for routine 
analysis in pharmaceutical industries.
•	 Mobile phase containing more than 50% organic phase 
may be detrimental to HPLC column as at that concen-
tration, buffer salts may precipitate.
•	 In some methods, shape and tailing do not seem to be 
satisfactory.
•	 Stress degradation studies and their chromatograms were 
not shown properly.
Herein we put an effort to develop a cost-effective, rapid, 
and robust reversed phase (RP)-HPLC method with enough 
data of validation parameters. First, pKa of drugs was inves-
tigated. pKa of paracetamol and ibuprofen was 9.5 and 4.85, 
respectively. As a rule of thumb, pH of mobile phase is selected 
two units above or below the pKa value of drug. If we con-
sider pKa of paracetamol, then we cannot choose the pH above 
9.5, which is detrimental to silica beds of column. Therefore, 
the choice is two units below the pKa of paracetamol. Again, 
with respect to ibuprofen, we could choose the pH of mobile 
phase two units below of its pKa (4.8), but at that acidic pH, 
ibuprofen remains fully undissociated, which results in strong 
hydrophobic attraction with silica bed and, consequently, 
longer retention of this drug. Therefore, we thought a pH of 
around 7.0, which will be about two units far from the pKa of 
both drugs, and at this pH, both drugs will remain ionized, 
which makes the retention time much shorter at lower organic 
concentration. Thus, we tried with different buffers having a 
pH between 6.5 and 7.5 with different ratios of acetonitrile and 
methanol in isocratic   condition. But we discarded methanol as 
it took longer time to elute ibuprofen. So our ultimate choice 
was acetonitrile, and at 35% concentration, the method gave 
well-  resoluted and sharp peaks of paracetamol and ibuprofen. 
It was found that with increased pH, retention of ibuprofen 
was decreased. Thus, finally, a pH of 6.8 was chosen so as to get 
sufficient resolution between the peaks. The method is summa-
rized in Table 1. Typical chromatogram is shown in Figure 2. 
This study was validated according to the guidelines of Inter-
national Conference on Harmonisation (ICH) and USP.9,10
Materials and Methods
Materials. Working standards of paracetamol and ibu-
profen were a kind gift of Healthcare Pharmaceuticals Limited, 
Rajendrapur, Bangladesh. HPLC grade acetonitrile was pur-
chased from Active Fine Chemicals Ltd., Dhaka, Bangladesh.
HPLC system. High-performance liquid chromato-
graphic system (Shimadzu-Prominence, Japan), equipped with 
an auto sampler (Model—SIL-20AC HT) and UV–  visible 
detector (Model—SPD 20A), was used for the analysis. The 
data were recorded using LC-solution software. Analytical 
RP C18 column [octadecylsilane (ODS), 150 × 4.6 mm, 5 μ, 
Phenomenex Inc., Japan] was used to analyze the standard 
and samples.
Preparation of mobile phase. A total of 1.75 g of dipo-
tassium hydrogen phosphate salt was dissolved in 900 mL of 
nanopure water. pH was adjusted to 6.8 ± 0.1 with diluted 
phosphoric acid or sodium hydroxide, and then volume was 
made up to 1000 mL with water of the same quality. Then this 
buffer and HPLC grade acetonitrile were mixed together at a 
ratio of 65:35, v/v. Finally, it was filtered through a 0.22-μm 
Millipore filter and sonicated to degas.
Preparation of standard solutions.  In all, 50  mg of 
paracetamol and 20 mg of ibuprofen were taken in a 100-mL 
volumetric flask, and about 50 mL diluting solution (as mobile 
phase) was added and sonicated for five minutes to dissolve 
properly. Then volume was made up to the mark with the 
same diluent. This was stock solution. A total of 5 mL of this 
solution was taken into a 50-mL volumetric flask and diluted 
with diluents up to the mark. Thus, we got the test solution 
of paracetamol and ibuprofen of a concentration of 50 and 
20 μg/mL, respectively. The stock solution was further diluted 
to get 50–200% of test concentration.
Figure 1. structure of (A) paracetamol and (B) ibuprofen.
Table 1. Newly developed RP-HPLC method.
Mobile phase: Phosphate buffer (pH 6.8): Acetonitrile = 65:35, v/v
column: c18 (150 × 4.6 mm, 5 μ, Phenomenex Inc.)
Flow rate: 0.7 ml/min
Wave length: 222 nm
Retention time: Paracetamol: 2.8 ±	0.1 min, Ibuprofen: 4.7 ±	0.1 min
Tailing factor: Paracetamol: 1.3, Ibuprofen: 1.1
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Chromatographic conditions. All analyses were done 
at ambient temperature under isocratic condition. The mobile 
phase was run at a flow rate of 0.7 mL/minute for seven min-
utes. The injection volume was 10 μL for standard and samples. 
Before analysis, every standard and sample was filtered through 
0.2 μm filter tips. The column eluent was monitored with UV 
detection at 222 nm.
Method validation. The method was validated accord-
ing to United States of Pharmacopeia (USP) guideline with 
respect to accuracy, precision, specificity, linearity, solution 
stability, robustness, sensitivity, and system suitability.10 
Forced degradation was validated according to ICH.9,11,12
Specificity.  The specificity of the LC method was 
evaluated to ensure that there was no interference from the 
degradation products, excipients, or other impurities in the 
region of actives. The specificity was studied by injecting 
the unstressed and stressed standard solutions, samples, and 
blanks.
Solution stability. Stability of drugs in diluting solvent 
and mobile phase was checked by rendering the test solutions 
in tightly capped vials at room temperature and in refrigerator 
at 5°C for three days. The solutions were analyzed by HPLC 
for three consecutive days.
Forced degradation.  Forced degradation studies are 
undertaken to degrade the active drug deliberately. These 
studies are used to evaluate an analytical method’s ability to 
measure an active ingredient and its degradation products 
without interference. Samples or drug product (spiked placebo) 
and drug substance are exposed to acid, base, oxidizing agent, 
reducing agent, and water. The degraded samples were then 
analyzed using the method to determine if there are interfer-
ences with the active. Thus, stability-indicating property was 
evaluated.
Linearity and range. Linearity was checked on seven 
different concentrations within 50–200% of the nominal stan-
dard concentration. The linearity of the proposed method was 
evaluated by using calibration curve to calculate coefficient of 
correlation, slope, and intercept values.
Accuracy. The accuracy of an analytical method expresses 
the nearness between the expected value and the value found. 
In the present study, successive analysis (n = 3) for three dif-
ferent concentrations of standard mixture (80, 100, and 120% 
of nominal concentration) was carried out to determine the 
accuracy of the proposed method.
Precision. The precision of the assay was assessed with 
respect to repeatability and reproducibility. The precision of the 
proposed method was checked by intra- and inter-day repeat-
ability of responses on different columns and different HPLC 
machines after replicate injections and expressed as %RSD 
among responses using the formula [%RSD  =  (standard 
deviation/mean) × 100%].
Robustness. Robustness is an indication of reliability of 
the analytical method during normal usage. The effect of the 
following deliberate changes in chromatographic conditions 
was monitored: flow rate ±50%, solvent ratio ±15%, pH of 
buffer solution ±0.2, temperature ±10°C, and detector wave-
length ±3.
System suitability. The purpose of the system suitability 
test is to ensure that the complete testing system, including 
instruments, reagents, columns, analysts etc., is adequate for 
the intended analysis. The following parameters are usually 
determined: theoretical plate count, tailing factors, resolution, 
and reproducibility.
Limit of detection (LOD) and limit of quantitation 
(LOQ). LOD is the lowest amount of analyte in a sample 
that can be detected but not necessarily quantitated under the 
stated experimental conditions. On the other hand, LOQ is 
the lowest amount of analyte in a sample that may be deter-
mined with acceptable accuracy and precision.
Results and Discussion
Specificity. The specificity was studied by injecting the 
unstressed and stressed standard solutions, blank, and phar-
maceutical preparation of these drugs combination, several 
times on several days. It was revealed that there was no inter-
ference of peak in the region of paracetamol and ibuprofen in 
chromatogram for the stressed sample, placebo, and active. 
Specificity was further confirmed by peak purity index. 
Hence, the method was considered specific for the product. 
Representative chromatograms of blank, standard, and sam-
ple are shown in Figure 2, and peak purity index is shown in 
Figure 3.
Solution stability. Two vials were prepared containing 
the standard mixture in diluting solution. One vial was kept in 
Figure 2. Chromatograms of blank, standard, and sample.Asma et al
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room temperature and another in refrigerator. Area change was 
investigated up to three consecutive days. %RSD of areas for all 
drugs were well between the limit (1.3%), which demonstrated 
that the drugs were fairly stable in the diluting solution and in 
the mobile phase. Results are shown in Table 2.
Forced degradation. Standard mixture was exposed to 
water, acid (1.0N HCl), base (1.0N NaOH), oxidizing agent 
(10% H2O2), and reducing agent (10% sodium bisulfate) for 
24 hours. Results are summarized in Table 3. Degradation of 
drug substances between 5 and 20% has been accepted for val-
idation of chromatographic assays.11,12 From the results, it was 
found that paracetamol was degraded significantly by oxida-
tion. It also exhibited degradation in basic condition. One very 
notable finding is that ibuprofen remained completely stable in 
acid media. ibuprofen showed degradation in strong basic con-
dition, but it was within the limit. In case of water hydrolysis, 
degradation was below the limit for both drugs. That is why 
we chose the pH of buffer in acidic region and close to neutral 
pH. Chromatograms are shown in Figure 4.
Linearity, accuracy, and precision. Linearity of the 
standard mixture was examined on 50–200% of nominal con-
centration. According to USP, the correlation coefficient (R2) 
for a calibration curve must be 0.995.10 The correlation coef-
ficient was found to be more than 0.995 for both drugs indi-
cating good linearity of calibration curve. The linearity curves 
are shown in Figure 5.
For paracetamol, percent recovery is found to be 101.2, 
100.5, and 99.9% for 40, 45, and 50 μg/mL, respectively, and 
for ibuprofen, percent recovery is found to be 101.1, 100.4, 
and 100.2% for 16, 18, and 20 μg/mL, respectively, shown 
in Table 4. All experimental results are in the range of the 
acceptability for accuracy (97.0–103.0%).10
The %RSD values found in precision study depicted in 
Table 5 showed that the proposed method provides acceptable 
intra- and inter-day variations for paracetamol and ibuprofen 
in their simultaneous determination. Results are summarized 
in Table 5 where %RSD was within the limit 2.10
System suitability. All system suitability parameters, 
including peak area, theoretical plate, tailing factor, reten-
tion time, and resolution, met the compendium acceptance 
limits.10 Results are summarized in Table 6.
Robustness. Predetermined variations were performed 
under the experimental conditions to assess their robustness. 
We changed pH ±0.4, flow rate ±0.3, wave length ±10, and 
organic concentration ±3.5 units. Results are shown in Table 7.
Conclusion
Hereby a new and robust method was developed for simul-
taneous quantification of paracetamol and ibuprofen in their 
solid dosage form. We validated it strictly maintaining the 
guidelines of ICH, USP, and Food and Drug Administra-
tion (FDA). The method was primarily designed for assay of 
Figure 3. Peak purity of paracetamol and ibuprofen.
Table 2. Results of solution stability.
DAY ROOM TEMPERATURE REFRIGERATOR
PARA IBU PARA IBU
Day 1 1548146 782314 1548146 782314
Day 2 1540987 770193 1542538 779734
Day 3 1538988 765330 1541885 779556
%rsD 0.312 1.13 0.223 0.198
Table 3. summary of stress degradation study.
DRUG % OF DEGRADATION AGAINST FRESHLY PREPARED 
STANDARDa
  ACID BASE WATER OXIDATION REDUCTION
PARA 19.9 32.5 2.02 53.4 2.83
IBU 0 15.9 1.97 7.38 1.62
Note: amean of three runs.A study of method development, validation, and forced degradation 
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paracetamol and ibuprofen in tablet or capsule. Moreover, the 
content of degradation of paracetamol and ibuprofen in vari-
ous conditions, such as alkaline, acidic, oxidation, reduction 
and water hydrolysis, were observed and quantitatively ana-
lyzed by this HPLC method. The information, thus, obtained 
will facilitate pharmaceutical development in areas such as 
formulation development, manufacturing, and packaging, 
where knowledge of chemical behavior can be used to improve 
the quality of drug product.
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Figure 4. Chromatograms of stressed condition, clockwise from top-left corner: acid, base, reduction, and oxidation. Peaks of paracetamol and 
ibuprofen were identified by their retention time, and rest of the peaks was of unknown degradants.
Figure 5. linearity curve of (A) paracetamol and (B) ibuprofen.Asma et al
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Table 4. Accuracy (% recovery) of paracetamol and ibuprofen.
INJECTED CONC. OF  
PARACETAMOL  
(µg/mL)
MEAN RECOVERED  
CONC. OF PARACETAMOL  
(µg/mL)
% RECOVERY OF  
PARACETAMOL
INJECTED CONC. OF  
IBUPROFEN  
(µg/mL)
MEAN RECOVERED  
CONC. OF IBUPROFEN  
(µg/mL)
% RECOVERY  
OF IBUPROFEN
40 40.48 101.2 16 16.17 101.1
45 45.23 100.5 18 18.07 100.4
50 49.95 99.9 20 20.04 100.2
Table 5. results of method validation parameters.
PARAMETERS LIMITS PARACETAMOL IBUPROFEN
linear equation y =	32767x–88823 y =	32950x–595
Correlation coefficient (R2) 0.995 0.999 1.00
linearity range 25–100 μg/ml 10–40 μg/ml 
Precision(intra-day)a: %rsD  2%
Day 1, Analyst 1, column 1 0.956% 0.821%
Day 2, Analyst 2, column 2 1.344% 1.937%
Day 3, Analyst 3, column 3 1.987% 1.124%
Precision(inter-day): %rsD  3% 2.11% 2.034% 
lOD s/n =	3:1 2.3 μg/ml 0.213 μg/ml
lOQ s/n =	10:1 7.9 μg/ml 0.711 μg/ml
Note: aMean of six runs.
Table 6. System suitability parameters.
PARAMETER PARACETAMOL IBUPROFEN USP LIMIT
%rsD of tr
a 0.225 0.114 2%
%rsD of areaa 0.223 0.198 2%
tailing factora 1.3 1.1 2.0
resolutionb – 6.5 2.0%
theoretical plate 2100 3743 2000
Peak purity index 1.00 1.00 0.98
Notes: aMean of six runs. bResolution with respect to former peak.
Table 7. Summary of robustness.
PARAMETER CHANGES ACTUAL VALUES RETENTION TIME TAILING FACTOR PEAK PURITY
PARA IBU PARA IBU PARA IBU
ph ±0.4
7.2 2.9 4.1 1.2 1.1 1.00 1.00 
6.2 2.4 5.4 1.3 1.2 1.00 1.00
Flow rate ±0.3
1.0 1.6 3.1 1.1 1.2 0.99 0.99
0.4 3.8 6.3 1.5 1.3 1.00 1.00
Wave length ±10
212 2.8 4.7 1.3 1.1 1.00 1.00
232 2.7 4.7 1.3 1.1 1.00 1.00
Organic concentration ±3.5
38.5% 2.1 4.2 1.2 1.1 0.99 0.99
31.5% 3.0 12.4 1.3 1.2 1.00 0.99A study of method development, validation, and forced degradation 
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